MYCOPHENOLATE MOFETIL

MYCOPHENOLATE MOFETIL was reported 67469 times

MYCOPHENOLATE MOFETIL is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 SMOOTH MUSCLE CELL NEOPLASM 94 0.6483
1 TRANSPLANT DYSFUNCTION 727 0.6219
2 POLYOMAVIRUS-ASSOCIATED NEPHROPATHY 736 0.6169
3 TRICHODYSPLASIA SPINULOSA 118 0.6146
4 DELAYED GRAFT FUNCTION 233 0.5974
5 RENAL GRAFT INFECTION 60 0.5769
6 CYTOMEGALOVIRUS SYNDROME 65 0.5603
7 PHAEOHYPHOMYCOSIS 107 0.5515
8 CHRONIC ALLOGRAFT NEPHROPATHY 295 0.5473
9 EXTERNAL AUDITORY CANAL ATRESIA 72 0.5217
10 HEART TRANSPLANT REJECTION 386 0.5140
11 NEUTROPHIL PELGER-HUET ANOMALY PRESENT 77 0.5133
12 TRANSPLANT REJECTION 2634 0.5106
13 PANCREAS TRANSPLANT REJECTION 71 0.4581
14 COMPLICATIONS OF TRANSPLANTED HEART 73 0.4506
15 HUMAN POLYOMAVIRUS INFECTION 123 0.4346
16 COMPLICATIONS OF TRANSPLANTED KIDNEY 687 0.4288
17 BK VIRUS INFECTION 731 0.4223
18 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 1044 0.4179
19 POLYOMAVIRUS VIRAEMIA 86 0.4135
20 GRAFT DYSFUNCTION 118 0.4069
21 PARVOVIRUS B19 INFECTION 114 0.3958
22 MICROTIA 112 0.3930
23 KIDNEY TRANSPLANT REJECTION 1423 0.3887
24 LUNG TRANSPLANT REJECTION 166 0.3825
25 CYTOMEGALOVIRUS GASTROINTESTINAL INFECTION 61 0.3742
26 SLE ARTHRITIS 74 0.3627
27 CHRONIC GRAFT VERSUS HOST DISEASE IN SKIN 150 0.3614
28 RENAL TRANSPLANT FAILURE 206 0.3601
29 CYSTITIS VIRAL 59 0.3576
30 ALTERNARIA INFECTION 60 0.3571
31 CRYPTOSPORIDIOSIS INFECTION 94 0.3547
32 GRAFT LOSS 205 0.3541
33 COMPLICATIONS OF TRANSPLANTED LUNG 60 0.3529
34 LYMPHOCELE 195 0.3397
35 CHRONIC GRAFT VERSUS HOST DISEASE IN LIVER 57 0.3393
36 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 381 0.3390
37 GRAFT VERSUS HOST DISEASE IN LUNG 93 0.3286
38 ACUTE GRAFT VERSUS HOST DISEASE IN LIVER 144 0.3236
39 ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE 276 0.3232
40 CYTOMEGALOVIRUS VIRAEMIA 658 0.3200
41 MICROSPORIDIA INFECTION 62 0.3163
42 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 494 0.3137
43 LIVER TRANSPLANT REJECTION 422 0.3056
44 GRAFT VERSUS HOST DISEASE IN SKIN 374 0.2964
45 RENAL TUBULAR ATROPHY 160 0.2941
46 GRAFT VERSUS HOST DISEASE IN LIVER 119 0.2938
47 CYTOMEGALOVIRUS INFECTION 2970 0.2797
48 CYTOMEGALOVIRUS INFECTION REACTIVATION 170 0.2791
49 ELBOW DEFORMITY 73 0.2765
50 ADENOVIRUS INFECTION 423 0.2752
51 CYTOMEGALOVIRUS ENTERITIS 54 0.2727
52 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 507 0.2714
53 CHRONIC GRAFT VERSUS HOST DISEASE 589 0.2692
54 TRANSPLANT FAILURE 437 0.2652
55 ACUTE GRAFT VERSUS HOST DISEASE 812 0.2573
56 POST TRANSPLANT DISTAL LIMB SYNDROME 46 0.2570
57 EPSTEIN-BARR VIRAEMIA 130 0.2529
58 EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOMA 70 0.2527
59 VARICELLA ZOSTER VIRUS INFECTION 273 0.2505
60 CYTOMEGALOVIRUS ANTIGEN POSITIVE 46 0.2500
61 ENCEPHALITIS CYTOMEGALOVIRUS 49 0.2450
62 DERMATOPHYTOSIS 45 0.2419
63 IMMUNOSUPPRESSANT DRUG LEVEL DECREASED 207 0.2407
64 CHOROIDITIS 52 0.2396
65 HYPERCREATINAEMIA 52 0.2374
66 HUMAN HERPESVIRUS 8 INFECTION 62 0.2348
67 APOPTOSIS 48 0.2308
68 VIRAEMIA 167 0.2297
69 HEPATIC ARTERY THROMBOSIS 48 0.2286
70 GLOMERULONEPHRITIS MEMBRANOPROLIFERATIVE 76 0.2255
71 SCEDOSPORIUM INFECTION 81 0.2244
72 LUPUS NEPHRITIS 176 0.2234
73 CYTOMEGALOVIRUS COLITIS 255 0.2225
74 CEREBRAL TOXOPLASMOSIS 115 0.2220
75 VIRAL HAEMORRHAGIC CYSTITIS 73 0.2219
76 DISSEMINATED CRYPTOCOCCOSIS 68 0.2208
77 FOCAL SEGMENTAL GLOMERULOSCLEROSIS 198 0.2205
78 HUMAN HERPESVIRUS 6 INFECTION 300 0.2182
79 EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER 229 0.2171
80 JC VIRUS INFECTION 190 0.2144
81 INFECTION REACTIVATION 111 0.2118
82 PNEUMONIA CYTOMEGALOVIRAL 248 0.2116
83 EPSTEIN-BARR VIRUS INFECTION 833 0.2112
84 RENAL TUBULAR INJURY 65 0.2077
85 COMPLICATIONS OF TRANSPLANTED LIVER 62 0.2067
86 STRONGYLOIDIASIS 207 0.2060
87 TOXOPLASMOSIS 146 0.2039
88 NOCARDIOSIS 291 0.2021
89 CYTOMEGALOVIRUS TEST POSITIVE 234 0.2010
90 MUCORMYCOSIS 285 0.1987
91 HEPATITIS E 178 0.1987
92 WEST NILE VIRAL INFECTION 82 0.1981
93 ALVEOLAR PROTEINOSIS 58 0.1953
94 CRYPTOCOCCOSIS 155 0.1921
95 KIDNEY FIBROSIS 201 0.1821
96 CENTRAL NERVOUS SYSTEM LYMPHOMA 133 0.1800
97 URETERIC STENOSIS 102 0.1789
98 MYCOBACTERIUM ABSCESSUS INFECTION 60 0.1786
99 GRAFT VERSUS HOST DISEASE 919 0.1771
100 PARVOVIRUS INFECTION 46 0.1762
101 PNEUMOCYSTIS JIROVECII INFECTION 85 0.1710
102 OESOPHAGEAL ATRESIA 80 0.1623
103 HISTOPLASMOSIS DISSEMINATED 109 0.1562
104 ASPERGILLUS INFECTION 481 0.1553
105 OBLITERATIVE BRONCHIOLITIS 148 0.1542
106 INFECTION IN AN IMMUNOCOMPROMISED HOST 69 0.1494
107 THROMBOTIC MICROANGIOPATHY 783 0.1489
108 STEROID DIABETES 66 0.1473
109 COMPLICATIONS OF TRANSPLANT SURGERY 63 0.1469
110 EPSTEIN-BARR VIRUS TEST POSITIVE 64 0.1451
111 ENCEPHALITIS VIRAL 121 0.1449
112 CYSTITIS HAEMORRHAGIC 363 0.1407
113 ACINETOBACTER INFECTION 99 0.1398
114 GRAFT COMPLICATION 60 0.1392
115 MYCOPLASMA INFECTION 46 0.1326
116 BRONCHOPULMONARY ASPERGILLOSIS 579 0.1322
117 KLEBSIELLA INFECTION 377 0.1318
118 LEGIONELLA INFECTION 48 0.1266
119 APLASIA PURE RED CELL 299 0.1256
120 BLOOD IRON ABNORMAL 79 0.1254
121 KAPOSI'S SARCOMA 63 0.1248
122 MENINGITIS CRYPTOCOCCAL 119 0.1218
123 GLOMERULOSCLEROSIS 54 0.1216
124 MYCOBACTERIAL INFECTION 136 0.1210
125 IGA NEPHROPATHY 86 0.1198
126 BRAIN ABSCESS 176 0.1183
127 HYPOGAMMAGLOBULINAEMIA 340 0.1178
128 ZYGOMYCOSIS 53 0.1128
129 ENTEROCOCCAL INFECTION 328 0.1100
130 LYMPHOPROLIFERATIVE DISORDER 190 0.1094
131 CYTOMEGALOVIRUS ENTEROCOLITIS 45 0.1087
132 CYTOMEGALOVIRUS CHORIORETINITIS 125 0.1085
133 STENOTROPHOMONAS INFECTION 80 0.1083
134 HAEMOLYTIC URAEMIC SYNDROME 206 0.1081
135 PNEUMONIA CRYPTOCOCCAL 49 0.1072
136 KLEBSIELLA SEPSIS 77 0.1065
137 GASTROENTERITIS NOROVIRUS 110 0.1058
138 GLOMERULONEPHRITIS 160 0.1053
139 PNEUMOCYSTIS JIROVECII PNEUMONIA 543 0.1045
140 HERPES ZOSTER DISSEMINATED 50 0.1044
141 URINARY TRACT INFECTION ENTEROCOCCAL 74 0.1018
142 ASPERGILLOSIS 133 0.1014
143 COVID-19 PNEUMONIA 118 0.0995
144 ENTEROCOCCAL BACTERAEMIA 56 0.0977
145 ENTEROCOCCAL SEPSIS 58 0.0975
146 GRANULOMATOSIS WITH POLYANGIITIS 55 0.0943
147 PNEUMONIA KLEBSIELLA 102 0.0941
148 PYELONEPHRITIS ACUTE 119 0.0925
149 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 507 0.0909
150 PSEUDOMONAS INFECTION 456 0.0904
151 HISTOPLASMOSIS 110 0.0904
152 MICROANGIOPATHY 59 0.0901
153 DIFFUSE LARGE B-CELL LYMPHOMA 318 0.0888
154 GINGIVAL HYPERTROPHY 69 0.0882
155 NEPHROPATHY TOXIC 559 0.0878
156 SYSTEMIC MYCOSIS 56 0.0867
157 BACTERIAL SEPSIS 189 0.0866
158 SYSTEMIC CANDIDA 113 0.0859
159 RENAL ARTERY STENOSIS 87 0.0844
160 PNEUMONIA INFLUENZAL 54 0.0840
161 DRUG LEVEL FLUCTUATING 52 0.0833
162 FUNGAEMIA 76 0.0827
163 BILE DUCT STENOSIS 68 0.0823
164 BLOOD PRESSURE DIASTOLIC ABNORMAL 62 0.0814
165 ENTEROBACTER INFECTION 84 0.0811
166 CANDIDA SEPSIS 51 0.0802
167 ACTINIC KERATOSIS 145 0.0794
168 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 146 0.0785
169 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 138 0.0776
170 TRANSITIONAL CELL CARCINOMA 58 0.0772
171 GLOMERULONEPHRITIS MEMBRANOUS 52 0.0762
172 NEPHRECTOMY 65 0.0762
173 ACUTE MYELOID LEUKAEMIA RECURRENT 68 0.0744
174 RENAL TRANSPLANT 173 0.0739
175 PARAINFLUENZAE VIRUS INFECTION 63 0.0734
176 NEPHROTIC SYNDROME 322 0.0726
177 URINARY TRACT INFECTION BACTERIAL 105 0.0717
178 VENOOCCLUSIVE DISEASE 114 0.0708
179 RENAL TUBULAR NECROSIS 459 0.0707
180 ESCHERICHIA INFECTION 338 0.0684
181 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 387 0.0678
182 PNEUMOMEDIASTINUM 63 0.0666
183 PAPILLOMA VIRAL INFECTION 68 0.0663
184 CUSHINGOID 133 0.0657
185 VENOOCCLUSIVE LIVER DISEASE 191 0.0634
186 BRONCHIECTASIS 217 0.0632
187 MULTIPLE ORGAN DYSFUNCTION SYNDROME 823 0.0629
188 ESCHERICHIA SEPSIS 126 0.0627
189 MYCOBACTERIUM AVIUM COMPLEX INFECTION 90 0.0622
190 DIFFUSE ALVEOLAR DAMAGE 51 0.0618
191 COCCIDIOIDOMYCOSIS 49 0.0616
192 RHINOVIRUS INFECTION 91 0.0610
193 HERPES SIMPLEX 263 0.0603
194 PNEUMONIA FUNGAL 97 0.0595
195 ESCHERICHIA BACTERAEMIA 71 0.0579
196 PROTEINURIA 639 0.0576
197 HISTIOCYTOSIS HAEMATOPHAGIC 175 0.0576
198 ESCHERICHIA URINARY TRACT INFECTION 167 0.0573
199 PNEUMATOSIS INTESTINALIS 90 0.0572
200 PEMPHIGUS 158 0.0566
201 HEPATITIS B REACTIVATION 90 0.0555
202 PYELONEPHRITIS 306 0.0550
203 OPPORTUNISTIC INFECTION 71 0.0549
204 SQUAMOUS CELL CARCINOMA OF SKIN 195 0.0547
205 STAPHYLOCOCCAL BACTERAEMIA 136 0.0538
206 HEPATIC FIBROSIS 119 0.0534
207 SKIN INDURATION 76 0.0521
208 THERAPY PARTIAL RESPONDER 135 0.0521
209 RENAL TUBULAR DISORDER 115 0.0521
210 OVARIAN CYST 396 0.0519
211 LEUKAEMIA RECURRENT 64 0.0512
212 FUNGAL SKIN INFECTION 126 0.0508
213 BONE MARROW TOXICITY 62 0.0507
214 VARICELLA 86 0.0503
215 PSEUDOMONAL SEPSIS 58 0.0500
216 RED BLOOD CELL SEDIMENTATION RATE ABNORMAL 78 0.0500
217 BONE EROSION 94 0.0488
218 RENAL TUBULAR ACIDOSIS 63 0.0484
219 BACTERAEMIA 329 0.0481
220 DISSEMINATED TUBERCULOSIS 82 0.0476
221 URETERIC OBSTRUCTION 46 0.0466
222 BLOOD IMMUNOGLOBULIN G DECREASED 45 0.0464
223 ENCEPHALITIS 198 0.0462
224 NEPHROGENIC SYSTEMIC FIBROSIS 137 0.0461
225 SERUM SICKNESS 91 0.0459
226 PNEUMONIA VIRAL 84 0.0454
227 LYMPHOPENIA 374 0.0447
228 AUTOIMMUNE HAEMOLYTIC ANAEMIA 81 0.0445
229 WOUND DEHISCENCE 110 0.0438
230 FIBROSIS 93 0.0437
231 ACUTE RESPIRATORY DISTRESS SYNDROME 514 0.0436
232 B-CELL LYMPHOMA 106 0.0425
233 SQUAMOUS CELL CARCINOMA 264 0.0423
234 PNEUMONIA BACTERIAL 185 0.0423
235 COVID-19 519 0.0422
236 LARGE INTESTINAL ULCER 74 0.0421
237 CHOLANGITIS 153 0.0421
238 GRANULOMA 96 0.0420
239 HYDRONEPHROSIS 208 0.0419
240 AGRANULOCYTOSIS 463 0.0419
241 ORGANISING PNEUMONIA 111 0.0414
242 LEUKOPENIA 1349 0.0410
243 DERMATOMYOSITIS 56 0.0408
244 PNEUMONIA STAPHYLOCOCCAL 57 0.0408
245 SCLERODERMA 104 0.0406
246 PRODUCT USE IN UNAPPROVED INDICATION 4098 0.0405
247 SKIN HYPERTROPHY 74 0.0402
248 ENDOCARDITIS 135 0.0402
249 OESOPHAGEAL CANDIDIASIS 102 0.0400
250 PULMONARY ALVEOLAR HAEMORRHAGE 129 0.0392
251 SEPTIC SHOCK 1057 0.0391
252 PATHOGEN RESISTANCE 192 0.0390
253 NECROTISING FASCIITIS 87 0.0390
254 PNEUMOCYSTIS JIROVECI PNEUMONIA 87 0.0389
255 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 109 0.0387
256 INTENTIONAL PRODUCT USE ISSUE 1476 0.0387
257 LIVER ABSCESS 77 0.0381
258 HAEMODYNAMIC INSTABILITY 166 0.0376
259 DISEASE RECURRENCE 569 0.0376
260 BLOOD CREATININE INCREASED 1699 0.0375
261 HEPATIC NECROSIS 114 0.0374
262 LUNG ABSCESS 51 0.0373
263 LUNG CONSOLIDATION 71 0.0373
264 LEUKOENCEPHALOPATHY 100 0.0368
265 STAPHYLOCOCCAL SEPSIS 135 0.0364
266 DRUG LEVEL INCREASED 381 0.0364
267 PULMONARY TUBERCULOSIS 115 0.0359
268 CELL DEATH 46 0.0359
269 AZOTAEMIA 97 0.0359
270 APLASIA 57 0.0358
271 SKIN PAPILLOMA 95 0.0352
272 MYASTHENIA GRAVIS 103 0.0352
273 LUNG ADENOCARCINOMA 68 0.0351
274 NEPHRITIS 70 0.0350
275 MYOPATHY 207 0.0350
276 LIVER TRANSPLANT 92 0.0348
277 UROSEPSIS 202 0.0341
278 HAEMOLYTIC ANAEMIA 219 0.0340
279 STEM CELL TRANSPLANT 58 0.0339
280 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 113 0.0337
281 CANDIDA INFECTION 304 0.0332
282 OLIGURIA 147 0.0332
283 HEPATOSPLENOMEGALY 62 0.0325
284 HEPATITIS C 334 0.0323
285 HAEMODIALYSIS 250 0.0322
286 RESPIRATORY SYNCYTIAL VIRUS INFECTION 106 0.0322
287 CLOSTRIDIUM DIFFICILE COLITIS 225 0.0319
288 PROSTATITIS 67 0.0316
289 ANURIA 208 0.0315
290 SCIATICA 279 0.0314
291 GUILLAIN-BARRE SYNDROME 91 0.0311
292 RENAL IMPAIRMENT 1553 0.0309
293 ABDOMINAL INFECTION 46 0.0308
294 IMMUNOSUPPRESSION 141 0.0307
295 HERPES VIRUS INFECTION 118 0.0307
296 NEUROTOXICITY 290 0.0307
297 ADENOCARCINOMA 46 0.0306
298 C-REACTIVE PROTEIN ABNORMAL 78 0.0306
299 ENTERITIS 111 0.0304
300 HYPERURICAEMIA 84 0.0303
301 MULTI-ORGAN FAILURE 524 0.0302
302 WOUND INFECTION 172 0.0298
303 BACTERIAL INFECTION 329 0.0295
304 ENTEROCOLITIS 91 0.0294
305 SKIN NECROSIS 110 0.0293
306 AUTOIMMUNE HEPATITIS 126 0.0291
307 SYSTEMIC LUPUS ERYTHEMATOSUS 450 0.0291
308 PANCYTOPENIA 1036 0.0288
309 JAW FRACTURE 46 0.0285
310 HEPATITIS CHOLESTATIC 116 0.0284
311 DRUG LEVEL DECREASED 146 0.0283
312 BLOOD CULTURE POSITIVE 72 0.0280
313 LUNG INFILTRATION 203 0.0278
314 HYPERBILIRUBINAEMIA 186 0.0277
315 TUBULOINTERSTITIAL NEPHRITIS 326 0.0276
316 NECROSIS 112 0.0276
317 RESPIRATORY FAILURE 1395 0.0273
318 THROAT CANCER 50 0.0273
319 CANDIDIASIS 108 0.0268
320 BRAIN HERNIATION 56 0.0267
321 APHTHOUS ULCER 88 0.0267
322 THROMBOTIC THROMBOCYTOPENIC PURPURA 75 0.0266
323 DRUG RESISTANCE 393 0.0265
324 PULMONARY FUNCTION TEST DECREASED 81 0.0264
325 ENDOPHTHALMITIS 99 0.0263
326 HEPATITIS B 118 0.0262
327 BASAL CELL CARCINOMA 263 0.0262
328 DYSLIPIDAEMIA 84 0.0260
329 APLASTIC ANAEMIA 86 0.0257
330 SEPSIS 1913 0.0255
331 PAPULE 92 0.0254
332 URINE OUTPUT DECREASED 165 0.0254
333 PORTAL HYPERTENSION 52 0.0252
334 SUBCUTANEOUS ABSCESS 86 0.0252
335 DRUG LEVEL ABOVE THERAPEUTIC 54 0.0251
336 DYSMORPHISM 46 0.0251
337 NORMOCHROMIC NORMOCYTIC ANAEMIA 55 0.0250
338 PNEUMONIA ASPIRATION 406 0.0250
339 RALES 97 0.0250
340 CHOLESTASIS 309 0.0250
341 RENAL CELL CARCINOMA 88 0.0249
342 LUNG INFECTION 392 0.0248
343 VASCULITIS 181 0.0246
344 GASTROINTESTINAL TOXICITY 59 0.0246
345 CYTOPENIA 105 0.0243
346 CARDIAC TAMPONADE 78 0.0241
347 DISSEMINATED INTRAVASCULAR COAGULATION 255 0.0240
348 BONE MARROW FAILURE 424 0.0239
349 ODYNOPHAGIA 89 0.0237
350 END STAGE RENAL DISEASE 324 0.0234
351 PROTEIN URINE PRESENT 72 0.0234
352 ACIDOSIS 126 0.0234
353 ASCITES 464 0.0233
354 HYPOALBUMINAEMIA 112 0.0232
355 BLOOD CREATINE INCREASED 65 0.0228
356 MENINGITIS 103 0.0228
357 HEPATOCELLULAR CARCINOMA 119 0.0228
358 HAEMATOTOXICITY 109 0.0227
359 MENINGITIS ASEPTIC 63 0.0226
360 LARGE INTESTINE PERFORATION 106 0.0226
361 CACHEXIA 80 0.0226
362 STAPHYLOCOCCAL INFECTION 540 0.0225
363 MYOCARDITIS 119 0.0224
364 OTITIS MEDIA 54 0.0223
365 DRUG LEVEL BELOW THERAPEUTIC 59 0.0223
366 ENCEPHALOPATHY 347 0.0222
367 POSTOPERATIVE WOUND INFECTION 91 0.0222
368 SPLENOMEGALY 177 0.0222
369 NEUROLOGICAL SYMPTOM 82 0.0221
370 SKIN MASS 86 0.0221
371 SHOCK HAEMORRHAGIC 115 0.0220
372 HYPERTRIGLYCERIDAEMIA 82 0.0220
373 GROWTH RETARDATION 46 0.0220
374 OESOPHAGEAL ULCER 63 0.0220
375 MUCOSAL INFLAMMATION 372 0.0220
376 CHRONIC MYELOID LEUKAEMIA 67 0.0216
377 PORTAL VEIN THROMBOSIS 47 0.0216
378 UVEITIS 142 0.0215
379 CARDIAC FAILURE ACUTE 83 0.0215
380 FAILURE TO THRIVE 85 0.0215
381 HYPERAMMONAEMIA 68 0.0215
382 ARTHRITIS BACTERIAL 57 0.0212
383 SKIN TOXICITY 60 0.0212
384 FOLLICULITIS 57 0.0209
385 INTERSTITIAL LUNG DISEASE 623 0.0208
386 ACUTE RESPIRATORY FAILURE 233 0.0208
387 PULMONARY HAEMORRHAGE 121 0.0207
388 GASTROENTERITIS 208 0.0207
389 MYOSITIS 112 0.0207
390 CORONAVIRUS INFECTION 53 0.0205
391 HAEMOLYSIS 112 0.0204
392 RED BLOOD CELL SEDIMENTATION RATE INCREASED 140 0.0204
393 BLOOD UREA INCREASED 272 0.0203
394 TOXIC ENCEPHALOPATHY 56 0.0201
395 DEMYELINATION 57 0.0200
396 MULTIPLE ALLERGIES 87 0.0199
397 HYDROCEPHALUS 75 0.0199
398 TUBERCULOSIS 164 0.0197
399 LEFT VENTRICULAR HYPERTROPHY 60 0.0196
400 COLITIS 413 0.0195
401 HYPOXIA 429 0.0195
402 SKIN LESION 327 0.0193
403 FUNGAL INFECTION 412 0.0192
404 TREATMENT FAILURE 867 0.0190
405 HYPERCALCAEMIA 152 0.0189
406 POLYARTHRITIS 57 0.0189
407 BLOOD ALBUMIN DECREASED 108 0.0187
408 NEUTROPENIA 1366 0.0186
409 BRAIN OEDEMA 161 0.0186
410 HYPERKALAEMIA 441 0.0186
411 STATUS EPILEPTICUS 139 0.0185
412 SKIN TIGHTNESS 61 0.0185
413 RESPIRATORY DISTRESS 362 0.0184
414 LUNG TRANSPLANT 48 0.0184
415 TRANSAMINASES INCREASED 276 0.0183
416 SKIN INFECTION 119 0.0182
417 GLOMERULAR FILTRATION RATE DECREASED 114 0.0181
418 BLOOD BILIRUBIN INCREASED 360 0.0181
419 HYPOVOLAEMIA 75 0.0181
420 PERITONITIS 280 0.0180
421 THERAPY NON-RESPONDER 341 0.0180
422 ACUTE KIDNEY INJURY 1573 0.0180
423 ORAL CANDIDIASIS 145 0.0178
424 MOUTH ULCERATION 234 0.0178
425 RENAL FAILURE CHRONIC 137 0.0178
426 NEPHROPATHY 110 0.0178
427 ABDOMINAL ABSCESS 51 0.0178
428 HERPES ZOSTER 654 0.0175
429 STREPTOCOCCAL INFECTION 60 0.0174
430 BLOOD LACTATE DEHYDROGENASE INCREASED 212 0.0173
431 TYPE 1 DIABETES MELLITUS 63 0.0172
432 HEPATOTOXICITY 223 0.0171
433 FEBRILE NEUTROPENIA 652 0.0170
434 ATELECTASIS 122 0.0169
435 ACUTE HEPATIC FAILURE 142 0.0169
436 PSORIATIC ARTHROPATHY 309 0.0169
437 SYNOVITIS 133 0.0168
438 ACUTE PULMONARY OEDEMA 70 0.0168
439 CARDIOGENIC SHOCK 138 0.0167
440 ILEUS 138 0.0167
441 VENOUS THROMBOSIS 48 0.0166
442 MALNUTRITION 117 0.0166
443 ACUTE MYELOID LEUKAEMIA 166 0.0165
444 C-REACTIVE PROTEIN INCREASED 353 0.0165
445 DIARRHOEA HAEMORRHAGIC 101 0.0164
446 DIALYSIS 173 0.0164
447 INTRACRANIAL PRESSURE INCREASED 60 0.0163
448 HEPATIC FAILURE 354 0.0162
449 PERICARDITIS 95 0.0162
450 LIVER FUNCTION TEST ABNORMAL 391 0.0162
451 ANGIOPATHY 68 0.0161
452 DRUG INTERACTION 1741 0.0160
453 GLUCOSE TOLERANCE IMPAIRED 59 0.0159
454 ABSCESS 160 0.0158
455 DRUG INTOLERANCE 852 0.0158
456 METABOLIC ACIDOSIS 304 0.0157
457 PARTIAL SEIZURES 51 0.0156
458 IMMUNODEFICIENCY 110 0.0155
459 CLOSTRIDIAL INFECTION 47 0.0155
460 GASTROINTESTINAL INFECTION 85 0.0154
461 PNEUMOTHORAX 154 0.0154
462 PERICARDIAL EFFUSION 226 0.0154
463 LEUKOCYTOSIS 187 0.0154
464 CLOSTRIDIUM DIFFICILE INFECTION 192 0.0153
465 HAEMATURIA 383 0.0152
466 LEFT VENTRICULAR DYSFUNCTION 67 0.0151
467 INFECTION 1281 0.0151
468 RENAL FAILURE ACUTE 637 0.0150
469 METASTASES TO LYMPH NODES 58 0.0149
470 HEPATOCELLULAR INJURY 174 0.0149
471 ABDOMINAL TENDERNESS 53 0.0149
472 ABDOMINAL HERNIA 48 0.0148
473 DIABETES MELLITUS 805 0.0148
474 OESOPHAGITIS 111 0.0147
475 GENERALISED OEDEMA 119 0.0147
476 PULMONARY MASS 129 0.0146
477 THROMBOCYTOPENIA 1028 0.0145
478 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 400 0.0144
479 LUNG NEOPLASM 50 0.0144
480 HYPERKERATOSIS 52 0.0144
481 HAEMATOCRIT DECREASED 218 0.0144
482 SKIN PLAQUE 68 0.0144
483 PULMONARY FIBROSIS 164 0.0143
484 AUTOIMMUNE DISORDER 56 0.0143
485 NEPHROGENIC ANAEMIA 49 0.0143
486 GENERALISED TONIC-CLONIC SEIZURE 132 0.0142
487 SKIN CANCER 128 0.0142
488 OFF LABEL USE 5348 0.0141
489 HEPATITIS ACUTE 64 0.0141
490 CATATONIA 46 0.0140
491 MALIGNANT MELANOMA 126 0.0140
492 HEPATOMEGALY 104 0.0140
493 COMA 462 0.0139
494 ADRENAL INSUFFICIENCY 79 0.0139
495 PYREXIA 3146 0.0138
496 PNEUMONITIS 212 0.0138
497 METASTASES TO LUNG 95 0.0138
498 PLEURAL EFFUSION 580 0.0137
499 PULMONARY HYPERTENSION 207 0.0137
500 RENAL FAILURE 1345 0.0136
501 HYPOMAGNESAEMIA 110 0.0135
502 HYPERCHOLESTEROLAEMIA 76 0.0135
503 DUODENAL ULCER 68 0.0135
504 MALABSORPTION 47 0.0134
505 PLEURISY 62 0.0134
506 ORAL DISORDER 67 0.0134
507 MITRAL VALVE INCOMPETENCE 109 0.0133
508 NYSTAGMUS 52 0.0133
509 PANCREATITIS ACUTE 196 0.0132
510 HYPERLIPIDAEMIA 122 0.0131
511 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 88 0.0131
512 PEMPHIGOID 53 0.0131
513 ANAEMIA 1694 0.0130
514 LYMPHADENOPATHY 299 0.0129
515 TRICUSPID VALVE INCOMPETENCE 71 0.0129
516 HEPATIC FUNCTION ABNORMAL 290 0.0129
517 DEVICE RELATED INFECTION 147 0.0128
518 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 78 0.0127
519 HYPOPHOSPHATAEMIA 55 0.0126
520 RESPIRATORY TRACT INFECTION 198 0.0126
521 SKIN ULCER 218 0.0126
522 COAGULOPATHY 152 0.0125
523 MENTAL STATUS CHANGES 247 0.0124
524 GASTROINTESTINAL DISORDER 565 0.0124
525 HYPERGLYCAEMIA 311 0.0123
526 URINARY TRACT INFECTION 1288 0.0122
527 VIRAL INFECTION 258 0.0122
528 HEMIPARESIS 154 0.0121
529 HEPATITIS 210 0.0121
530 PNEUMONIA 2486 0.0121
531 HEPATIC CIRRHOSIS 141 0.0120
532 VIRAL UPPER RESPIRATORY TRACT INFECTION 48 0.0120
533 LYMPHOMA 114 0.0120
534 LOW BIRTH WEIGHT BABY 57 0.0120
535 MYELODYSPLASTIC SYNDROME 122 0.0120
536 DYSPNOEA EXERTIONAL 265 0.0119
537 TACHYPNOEA 97 0.0119
538 GASTRIC ULCER 163 0.0118
539 FLUID OVERLOAD 166 0.0118
540 CELLULITIS 409 0.0117
541 SHOCK 174 0.0116
542 LUNG DISORDER 356 0.0116
543 JOINT EFFUSION 55 0.0116
544 CORONARY ARTERY STENOSIS 46 0.0116
545 HYPERTHERMIA 62 0.0116
546 NEUTROPENIC SEPSIS 57 0.0115
547 OEDEMA 410 0.0114
548 SMALL INTESTINAL OBSTRUCTION 92 0.0114
549 IRON DEFICIENCY ANAEMIA 71 0.0113
550 HAEMORRHAGE INTRACRANIAL 133 0.0113
551 HEPATIC ENCEPHALOPATHY 75 0.0113
552 BLOOD DISORDER 60 0.0113
553 BLOOD ALKALINE PHOSPHATASE INCREASED 218 0.0112
554 FLANK PAIN 70 0.0112
555 CONCOMITANT DISEASE AGGRAVATED 48 0.0112
556 FACIAL PARALYSIS 54 0.0112
557 SUBARACHNOID HAEMORRHAGE 78 0.0111
558 GAMMA-GLUTAMYLTRANSFERASE INCREASED 187 0.0110
559 METASTASIS 47 0.0109
560 HAEMOGLOBIN DECREASED 761 0.0108
561 CONTRAINDICATED PRODUCT ADMINISTERED 147 0.0107
562 ALANINE AMINOTRANSFERASE INCREASED 471 0.0107
563 POLYNEUROPATHY 72 0.0106
564 DRUG TOXICITY 145 0.0106
565 INFLAMMATION 296 0.0106
566 ORAL HERPES 119 0.0106
567 CENTRAL NERVOUS SYSTEM LESION 114 0.0106
568 HEMIPLEGIA 64 0.0105
569 ATRIAL FLUTTER 61 0.0105
570 ATAXIA 90 0.0105
571 PREMATURE DELIVERY 102 0.0105
572 INTESTINAL PERFORATION 79 0.0104
573 ULCER 110 0.0104
574 ECCHYMOSIS 54 0.0104
575 PROTHROMBIN TIME PROLONGED 53 0.0103
576 GRAND MAL CONVULSION 95 0.0103
577 EYELID PTOSIS 67 0.0103
578 RENAL DISORDER 310 0.0102
579 POST PROCEDURAL COMPLICATION 141 0.0102
580 EXPOSURE DURING PREGNANCY 365 0.0102
581 HAEMATOMA 194 0.0101
582 THERAPEUTIC RESPONSE DECREASED 384 0.0101
583 MUSCLE ATROPHY 79 0.0101
584 PULMONARY OEDEMA 310 0.0101
585 ELECTROLYTE IMBALANCE 72 0.0100
586 ARTERIOSCLEROSIS 66 0.0099
587 OSTEONECROSIS 229 0.0099
588 VISUAL FIELD DEFECT 54 0.0099
589 SKIN HYPERPIGMENTATION 58 0.0098
590 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 221 0.0098
591 JOINT RANGE OF MOTION DECREASED 68 0.0097
592 ABORTION SPONTANEOUS 284 0.0097
593 ASPARTATE AMINOTRANSFERASE INCREASED 375 0.0097
594 ALTERED STATE OF CONSCIOUSNESS 127 0.0097
595 CONDITION AGGRAVATED 1524 0.0097
596 BLOOD PRESSURE SYSTOLIC INCREASED 105 0.0096
597 LOWER GASTROINTESTINAL HAEMORRHAGE 56 0.0095
598 NODULE 78 0.0095
599 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 54 0.0094
600 OSTEOPOROSIS 242 0.0094
601 PHOTOSENSITIVITY REACTION 105 0.0094
602 OSTEOMYELITIS 127 0.0094
603 UPPER RESPIRATORY TRACT INFECTION 285 0.0094
604 CARDIAC FAILURE 493 0.0094
605 RIGHT VENTRICULAR FAILURE 51 0.0093
606 PURPURA 60 0.0093
607 TOXICITY TO VARIOUS AGENTS 948 0.0092
608 JAUNDICE 192 0.0092
609 OSTEOPENIA 84 0.0092
610 OPTIC NEURITIS 60 0.0092
611 ACNE 491 0.0091
612 ACUTE CORONARY SYNDROME 58 0.0091
613 SINUSITIS 594 0.0091
614 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 168 0.0091
615 PRODUCTIVE COUGH 247 0.0091
616 RENAL CYST 51 0.0091
617 CHOLECYSTITIS 75 0.0090
618 EOSINOPHILIA 97 0.0090
619 EJECTION FRACTION DECREASED 85 0.0089
620 PETECHIAE 64 0.0089
621 LIPASE INCREASED 48 0.0089
622 NEOPLASM 59 0.0088
623 BLOOD POTASSIUM INCREASED 99 0.0088
624 CARDIOMYOPATHY 93 0.0088
625 GOUT 103 0.0088
626 HAEMOPTYSIS 174 0.0087
627 DIPLOPIA 149 0.0087
628 POLYURIA 47 0.0086
629 SENSORY LOSS 48 0.0086
630 MYOCLONUS 71 0.0086
631 OXYGEN SATURATION DECREASED 259 0.0086
632 DIARRHOEA 3370 0.0086
633 DIVERTICULITIS 153 0.0085
634 NEUTROPHIL COUNT INCREASED 61 0.0085
635 CEREBRAL INFARCTION 150 0.0085
636 INFUSION RELATED REACTION 276 0.0085
637 LYMPHOCYTE COUNT DECREASED 94 0.0084
638 RHABDOMYOLYSIS 246 0.0084
639 APHASIA 178 0.0084
640 RHEUMATOID ARTHRITIS 563 0.0084
641 BLOOD IRON DECREASED 53 0.0084
642 INFLAMMATORY BOWEL DISEASE 62 0.0083
643 SPINAL COMPRESSION FRACTURE 50 0.0083
644 DRUG-INDUCED LIVER INJURY 117 0.0082
645 CIRCULATORY COLLAPSE 106 0.0082
646 RED BLOOD CELL COUNT DECREASED 145 0.0082
647 LOWER RESPIRATORY TRACT INFECTION 210 0.0081
648 PULMONARY ARTERIAL HYPERTENSION 87 0.0081
649 APPENDICITIS 45 0.0081
650 CEREBRAL HAEMORRHAGE 206 0.0081
651 PERITONITIS BACTERIAL 62 0.0080
652 IMPAIRED HEALING 163 0.0080
653 GASTRITIS 146 0.0080
654 MASS 77 0.0080
655 RESPIRATORY RATE INCREASED 47 0.0080
656 RESPIRATORY DISORDER 158 0.0079
657 DISEASE PROGRESSION 513 0.0079
658 POST PROCEDURAL HAEMORRHAGE 68 0.0079
659 GASTROOESOPHAGEAL REFLUX DISEASE 412 0.0079
660 HYPOCALCAEMIA 97 0.0078
661 CATARACT 276 0.0078
662 DIVERTICULUM 47 0.0078
663 PREMATURE BABY 158 0.0077
664 BLINDNESS 194 0.0076
665 PLATELET COUNT DECREASED 503 0.0076
666 EPILEPSY 142 0.0076
667 NO THERAPEUTIC RESPONSE 93 0.0076
668 GENERAL PHYSICAL HEALTH DETERIORATION 489 0.0076
669 ASPIRATION 53 0.0076
670 HYPERTENSION 1038 0.0076
671 TENDERNESS 54 0.0076
672 THERAPEUTIC PRODUCT EFFECT DECREASED 112 0.0075
673 ABDOMINAL PAIN 1152 0.0075
674 PLATELET COUNT INCREASED 61 0.0075
675 TREATMENT NONCOMPLIANCE 234 0.0074
676 CARDIOMEGALY 73 0.0074
677 MATERNAL EXPOSURE DURING PREGNANCY 302 0.0073
678 METASTASES TO LIVER 79 0.0073
679 LIVER INJURY 77 0.0073
680 RENAL PAIN 49 0.0072
681 NERVOUS SYSTEM DISORDER 176 0.0072
682 TRANSFUSION 51 0.0071
683 CHRONIC KIDNEY DISEASE 394 0.0071
684 FISTULA 47 0.0070
685 HYPONATRAEMIA 272 0.0070
686 HYPOKALAEMIA 207 0.0069
687 JOINT STIFFNESS 119 0.0069
688 PANCREATITIS 262 0.0069
689 GASTROENTERITIS VIRAL 78 0.0069
690 RASH MACULO-PAPULAR 97 0.0069
691 ATRIAL SEPTAL DEFECT 46 0.0069
692 KIDNEY INFECTION 84 0.0069
693 SCAR 82 0.0068
694 DIABETES MELLITUS INADEQUATE CONTROL 83 0.0068
695 MELAENA 108 0.0068
696 MOTOR DYSFUNCTION 46 0.0068
697 IMMUNE SYSTEM DISORDER 55 0.0068
698 CARDIAC ARREST 403 0.0068
699 DEHYDRATION 631 0.0067
700 STOMATITIS 246 0.0067
701 TACHYCARDIA 396 0.0067
702 WHITE BLOOD CELL COUNT DECREASED 443 0.0067
703 INTRAOCULAR PRESSURE INCREASED 62 0.0067
704 CARDIAC MURMUR 46 0.0067
705 INTESTINAL OBSTRUCTION 152 0.0067
706 PHARYNGITIS 58 0.0067
707 ABORTION INDUCED 49 0.0067
708 PREGNANCY 110 0.0067
709 OEDEMA PERIPHERAL 623 0.0066
710 LUNG NEOPLASM MALIGNANT 130 0.0066
711 HEPATIC ENZYME INCREASED 261 0.0066
712 OBESITY 65 0.0065
713 ATRIAL FIBRILLATION 413 0.0065
714 PARALYSIS 65 0.0065
715 QUALITY OF LIFE DECREASED 59 0.0065
716 MATERNAL DRUGS AFFECTING FOETUS 47 0.0065
717 DYSURIA 164 0.0064
718 EMPHYSEMA 47 0.0064
719 WEIGHT DECREASED 1139 0.0064
720 BLOOD CREATINE PHOSPHOKINASE INCREASED 143 0.0063
721 PAIN IN JAW 130 0.0063
722 DEEP VEIN THROMBOSIS 324 0.0063
723 COUGH 1054 0.0063
724 BLOOD PRESSURE FLUCTUATION 93 0.0063
725 LIVER DISORDER 178 0.0063
726 HYPOTENSION 821 0.0062
727 PHOTOPHOBIA 71 0.0062
728 NIGHT SWEATS 124 0.0062
729 BODY TEMPERATURE INCREASED 87 0.0062
730 VENTRICULAR TACHYCARDIA 70 0.0061
731 VENTRICULAR FIBRILLATION 49 0.0061
732 ILL-DEFINED DISORDER 150 0.0060
733 NEOPLASM MALIGNANT 210 0.0060
734 HYPOTHYROIDISM 114 0.0060
735 SINUS TACHYCARDIA 59 0.0060
736 PULMONARY CONGESTION 53 0.0060
737 CYSTITIS 132 0.0060
738 MUSCULAR WEAKNESS 460 0.0059
739 JOINT SWELLING 409 0.0059
740 SLEEP APNOEA SYNDROME 79 0.0059
741 ADVERSE REACTION 52 0.0059
742 MUSCULOSKELETAL PAIN 265 0.0059
743 SUBDURAL HAEMATOMA 63 0.0059
744 GASTROINTESTINAL HAEMORRHAGE 397 0.0059
745 WHITE BLOOD CELL COUNT INCREASED 162 0.0058
746 FOETAL EXPOSURE DURING PREGNANCY 280 0.0058
747 VISUAL ACUITY REDUCED 166 0.0058
748 MYOCARDIAL ISCHAEMIA 55 0.0058
749 HYPOPHAGIA 94 0.0058
750 DEPRESSED LEVEL OF CONSCIOUSNESS 154 0.0058
751 HEPATIC STEATOSIS 71 0.0057
752 PRODUCT USE ISSUE 606 0.0057
753 CARDIO-RESPIRATORY ARREST 181 0.0057
754 DELIRIUM 124 0.0057
755 COLON CANCER 52 0.0057
756 COLITIS ULCERATIVE 108 0.0057
757 ALOPECIA 740 0.0056
758 HALLUCINATION, VISUAL 71 0.0056
759 ACUTE MYOCARDIAL INFARCTION 124 0.0055
760 SEIZURE 340 0.0055
761 HAEMORRHOIDS 75 0.0055
762 URINARY RETENTION 120 0.0054
763 SKIN DISORDER 105 0.0054
764 VOMITING 1661 0.0054
765 DYSPHAGIA 334 0.0054
766 INFLUENZA 368 0.0054
767 LIVER FUNCTION TEST INCREASED 58 0.0054
768 PULMONARY EMBOLISM 378 0.0053
769 DIABETIC KETOACIDOSIS 85 0.0053
770 PLASMA CELL MYELOMA 117 0.0053
771 DERMATITIS 63 0.0052
772 DYSARTHRIA 140 0.0052
773 CONVULSION 298 0.0052
774 NEUTROPHIL COUNT DECREASED 116 0.0052
775 CHILLS 390 0.0051
776 ISCHAEMIC STROKE 65 0.0051
777 ARTHRITIS 245 0.0050
778 ABDOMINAL PAIN LOWER 89 0.0050
779 ANOREXIA 64 0.0050
780 TOXIC EPIDERMAL NECROLYSIS 49 0.0049
781 NEURALGIA 72 0.0049
782 DRUG INEFFECTIVE 3991 0.0049
783 BLOOD TRIGLYCERIDES INCREASED 65 0.0048
784 HAEMORRHAGE 327 0.0048
785 SWELLING 270 0.0048
786 CORONARY ARTERY DISEASE 126 0.0048
787 CONFUSIONAL STATE 541 0.0048
788 CONJUNCTIVITIS 47 0.0048
789 ARRHYTHMIA 164 0.0048
790 MUSCULOSKELETAL STIFFNESS 263 0.0048
791 RENAL INJURY 119 0.0048
792 HERNIA 56 0.0048
793 DISORIENTATION 141 0.0047
794 GLAUCOMA 61 0.0047
795 BLOOD SODIUM DECREASED 59 0.0047
796 FLUID RETENTION 164 0.0047
797 LOCALISED INFECTION 72 0.0047
798 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 68 0.0047
799 PROSTATE CANCER 79 0.0047
800 RASH ERYTHEMATOUS 126 0.0047
801 DECREASED APPETITE 657 0.0047
802 BRONCHITIS 250 0.0046
803 DYSPNOEA 1725 0.0046
804 TREMOR 541 0.0046
805 LETHARGY 188 0.0046
806 HAEMATOCHEZIA 143 0.0046
807 WOUND 60 0.0046
808 BLOOD PRESSURE DECREASED 200 0.0045
809 EYE PAIN 141 0.0045
810 UNRESPONSIVE TO STIMULI 79 0.0045
811 NECK PAIN 165 0.0045
812 THROMBOSIS 236 0.0044
813 DEAFNESS 73 0.0044
814 ECZEMA 68 0.0044
815 NEUROPATHY PERIPHERAL 238 0.0044
816 ASTHENIA 1070 0.0043
817 FOOT FRACTURE 55 0.0043
818 CHOLELITHIASIS 102 0.0043
819 MANIA 51 0.0042
820 UPPER GASTROINTESTINAL HAEMORRHAGE 53 0.0042
821 BLISTER 144 0.0042
822 PSYCHOTIC DISORDER 88 0.0042
823 ANAPHYLACTIC REACTION 136 0.0042
824 SOMNOLENCE 557 0.0041
825 RIB FRACTURE 55 0.0041
826 RASH PAPULAR 67 0.0041
827 CHEST PAIN 530 0.0040
828 NEPHROLITHIASIS 111 0.0040
829 FACE OEDEMA 48 0.0039
830 BLOOD POTASSIUM DECREASED 79 0.0039
831 PALLOR 67 0.0039
832 INTERVERTEBRAL DISC PROTRUSION 61 0.0039
833 ABDOMINAL DISTENSION 262 0.0039
834 BRADYCARDIA 143 0.0039
835 RASH 1004 0.0038
836 RHINORRHOEA 147 0.0038
837 SPEECH DISORDER 140 0.0038
838 COGNITIVE DISORDER 113 0.0038
839 COLORECTAL CANCER 46 0.0037
840 ABDOMINAL DISCOMFORT 375 0.0037
841 MYALGIA 435 0.0037
842 FRACTURE 52 0.0037
843 DRUG HYPERSENSITIVITY 506 0.0037
844 URINARY INCONTINENCE 76 0.0037
845 ARTHRALGIA 895 0.0037
846 AMNESIA 174 0.0037
847 ANGIOEDEMA 107 0.0037
848 BLOOD PRESSURE INCREASED 361 0.0037
849 NAUSEA 1900 0.0037
850 HEART RATE INCREASED 236 0.0037
851 WEIGHT INCREASED 519 0.0036
852 ANGINA PECTORIS 78 0.0036
853 EAR INFECTION 55 0.0036
854 RECTAL HAEMORRHAGE 111 0.0036
855 VISUAL IMPAIRMENT 259 0.0036
856 MALAISE 1095 0.0035
857 OROPHARYNGEAL PAIN 203 0.0035
858 HEART RATE DECREASED 75 0.0035
859 DEATH 1844 0.0035
860 MENTAL DISORDER 96 0.0035
861 NO ADVERSE EVENT 286 0.0035
862 INTERNATIONAL NORMALISED RATIO INCREASED 87 0.0034
863 HEADACHE 1433 0.0034
864 DRUG EFFECT INCOMPLETE 126 0.0034
865 DRUG EXPOSURE DURING PREGNANCY 117 0.0034
866 CARDIOVASCULAR DISORDER 74 0.0034
867 SURGERY 107 0.0034
868 HALLUCINATION 158 0.0034
869 BLOOD CHOLESTEROL INCREASED 103 0.0033
870 HYPOGLYCAEMIA 115 0.0033
871 GASTRIC DISORDER 92 0.0033
872 FATIGUE 1549 0.0033
873 SKIN DISCOLOURATION 98 0.0032
874 HAEMATEMESIS 58 0.0032
875 EYE DISORDER 65 0.0032
876 OSTEOARTHRITIS 85 0.0032
877 TYPE 2 DIABETES MELLITUS 74 0.0031
878 PERIPHERAL SWELLING 267 0.0031
879 OVERDOSE 370 0.0031
880 DRY EYE 69 0.0031
881 ABDOMINAL PAIN UPPER 404 0.0030
882 LOSS OF CONSCIOUSNESS 273 0.0030
883 EPISTAXIS 157 0.0030
884 LIMB INJURY 47 0.0030
885 PAIN 1084 0.0030
886 CONTUSION 187 0.0030
887 NASOPHARYNGITIS 340 0.0030
888 DISCOMFORT 90 0.0030
889 WHEEZING 95 0.0030
890 HIP FRACTURE 60 0.0029
891 CARDIAC FAILURE CONGESTIVE 198 0.0029
892 CEREBROVASCULAR ACCIDENT 362 0.0029
893 MOBILITY DECREASED 127 0.0029
894 BONE DENSITY DECREASED 52 0.0029
895 AGITATION 157 0.0029
896 MOOD ALTERED 54 0.0029
897 CHROMATURIA 46 0.0028
898 ERYTHEMA 384 0.0028
899 VERTIGO 119 0.0028
900 RESPIRATORY ARREST 63 0.0028
901 DYSKINESIA 78 0.0028
902 DYSPHONIA 103 0.0028
903 BACK PAIN 429 0.0028
904 MEDICATION ERROR 108 0.0028
905 CHEST DISCOMFORT 178 0.0028
906 PAIN IN EXTREMITY 559 0.0028
907 BLADDER CANCER 57 0.0028
908 NASAL CONGESTION 93 0.0027
909 LABORATORY TEST ABNORMAL 50 0.0027
910 DYSPEPSIA 171 0.0027
911 ACCIDENTAL OVERDOSE 62 0.0027
912 DYSSTASIA 52 0.0027
913 DISTURBANCE IN ATTENTION 99 0.0026
914 SWELLING FACE 114 0.0026
915 ABASIA 63 0.0025
916 GAIT DISTURBANCE 331 0.0025
917 HYPOAESTHESIA 257 0.0025
918 PARAESTHESIA 272 0.0025
919 THERAPY CESSATION 77 0.0025
920 MYOCARDIAL INFARCTION 358 0.0025
921 PRURITUS 518 0.0025
922 POLLAKIURIA 69 0.0025
923 TRANSIENT ISCHAEMIC ATTACK 63 0.0025
924 SYNCOPE 171 0.0025
925 BONE PAIN 96 0.0024
926 BLOOD GLUCOSE INCREASED 327 0.0024
927 SKIN EXFOLIATION 118 0.0024
928 MALIGNANT NEOPLASM PROGRESSION 137 0.0024
929 RESTLESSNESS 60 0.0023
930 FALL 511 0.0023
931 PALPITATIONS 181 0.0023
932 HEAD INJURY 47 0.0023
933 VISION BLURRED 201 0.0022
934 HYPERSENSITIVITY 267 0.0022
935 TINNITUS 69 0.0022
936 BURNING SENSATION 107 0.0022
937 DEPRESSED MOOD 74 0.0022
938 ABNORMAL BEHAVIOUR 71 0.0022
939 BREAST CANCER 83 0.0022
940 INSOMNIA 392 0.0021
941 DEPRESSION 351 0.0021
942 CARDIAC DISORDER 135 0.0021
943 SLEEP DISORDER 84 0.0021
944 MIGRAINE 118 0.0021
945 ARTHROPATHY 67 0.0020
946 UNEVALUABLE EVENT 105 0.0020
947 CONSTIPATION 255 0.0020
948 INFLUENZA LIKE ILLNESS 121 0.0020
949 MEMORY IMPAIRMENT 175 0.0019
950 RASH PRURITIC 64 0.0019
951 THROAT IRRITATION 53 0.0019
952 DIZZINESS 632 0.0019
953 INJURY 102 0.0019
954 HOSPITALISATION 148 0.0019
955 BALANCE DISORDER 111 0.0019
956 ROAD TRAFFIC ACCIDENT 53 0.0018
957 EMOTIONAL DISTRESS 95 0.0018
958 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 65 0.0018
959 FEELING HOT 73 0.0018
960 STRESS 78 0.0018
961 MUSCLE SPASMS 220 0.0018
962 ANXIETY 334 0.0017
963 DRY MOUTH 90 0.0017
964 URTICARIA 175 0.0017
965 DRUG EFFECT DECREASED 88 0.0016
966 DRUG ADMINISTRATION ERROR 50 0.0016
967 FLATULENCE 60 0.0016
968 FLUSHING 120 0.0016
969 ADVERSE EVENT 97 0.0015
970 ASTHMA 89 0.0015
971 MULTIPLE SCLEROSIS 48 0.0015
972 ADVERSE DRUG REACTION 68 0.0015
973 HYPERHIDROSIS 135 0.0015
974 PRODUCT SUBSTITUTION ISSUE 59 0.0015
975 INTENTIONAL PRODUCT MISUSE 80 0.0014
976 UNDERDOSE 69 0.0014
977 HOT FLUSH 62 0.0014
978 SUICIDE ATTEMPT 57 0.0014
979 DRUG DOSE OMISSION 226 0.0014
980 INTENTIONAL OVERDOSE 52 0.0013
981 AGGRESSION 49 0.0013
982 IRRITABILITY 57 0.0013
983 DRUG DEPENDENCE 66 0.0013
984 INCORRECT DOSE ADMINISTERED 127 0.0012
985 FEELING ABNORMAL 204 0.0012
986 DYSGEUSIA 59 0.0011
987 DRY SKIN 85 0.0011
988 PRODUCT DOSE OMISSION 76 0.0011
989 SUICIDAL IDEATION 69 0.0011
990 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 64 0.0009
991 PSORIASIS 70 0.0009
992 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 63 0.0006
993 PRODUCT QUALITY ISSUE 69 0.0006
994 INJECTION SITE PAIN 82 0.0005